Table 2.
Persistence of positively marked FSC clones
|
Percentage of ovarioles with positively marked FSC clones at 14 days
|
|||
|---|---|---|---|
| Genotype* | Total | AM | Normalized total |
| FRT42D control | 44 | 4 | 100 |
| mam | 7 | 0 | 16 |
| ptc | 58 | 24 | 132 |
| ptc mam | 9 | 1 | 20 |
| UAS-MamWT | 38 | 4 | 86 |
| mam;UAS-MamWT | 18 | 1 | 41 |
| ptc;UAS-MamWT | 56 | 14 | 127 |
| ptc mam;UAS-MamWT | 49 | 24 | 111 |
| UAS-MamN | 34 | 2 | 77 |
| mam;UAS-MamN | 10†,‡ | 0 | 23 |
| ptc;UAS-MamN | 49 | 18 | 111 |
| ptc mam;UAS-MamN | 19†,§ | 1 | 43 |
AM, percentage of ovarioles with `all marked' FSC derivatives.
*
UAS-Mam transgenes were expressed using tub-GAL4 and actin-GAL4.
†
Significantly different from control (P<1 × 10−5).
‡
Not significantly different from mam (P=0.36).
§
Difference from ptc mam over two such experiments marginally significant (P=0.046).